CAS: 2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
Fórmula:
C21H19F3N4O4
Pureza:
98%
Peso molecular:
448.3952
Ref: AN-AG01KL03
| 25mg | 172,00 € | |
| 50mg | 206,00 € | |
| 100mg | 464,00 € | |
| 250mg | 550,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
VU6012962
CAS:2313526-86-0
VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: …
Fórmula:
C21H19F3N4O4
Pureza:
98.31%
Forma y color:
Solid
Peso molecular:
448.4
Ref: TM-T13323
| 1mg | 36,00 € | |
| 2mg | 52,00 € | |
| 5mg | 78,00 € | |
| 10mg | 124,00 € | |
| 25mg | 233,00 € | |
| 50mg | 418,00 € | |
| 100mg | 611,00 € | |
| 1ml*10 (DMSO) | 85,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally …
Fórmula:
C21H19F3N4O4
Pureza:
Min. 95%
Peso molecular:
448.4 g/mol
Ref: 3D-NSD52686
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 12 de Junio de 2024
